DRMA News | Roxom Stocks

1 BTC

- USD

Loading market data...

Mkt Cap

$4.3M

Volume

2.46M

Next Earnings

November 13th

Chart Financials Earnings News About Insider Filings

Papulopustular Rosacea Market Report Now Available, Covers 11 Countries Across North America, Europe, and Asia-Pacific, Profiling Galderma, Journey Medical, Dermata Therapeutics, and Dr. Reddy's LaboratoriesThe global papulopustular rosacea market is projected to grow steadily through 2035, driven by rising prevalence, improved diagnosis, and demand for safer non-antibiotic treatments. Advanced therapies including topical ivermectin, azelaic acid, and minocycline foam are reshaping care. Key players include Galderma, Journey Medical, Dermata Therapeutics, and Dr. Reddy's Laboratories, with growth supported by dermatology R&D, innovative drug delivery, and telemedicine despite challenges like high treatment costs and underdiagnosis.GlobeNewswire Inc. · Aug 31, 2026

Stock Market Today: S&P 500, Dow Jones Futures Trade Mixed Amid Blip In Santa Claus Rally—Boeing, Freeport-McMoRan, Fonar In FocusU.S. stock futures traded mixed on Tuesday as the Santa Claus rally resumed after Monday's declines. Major indices showed minimal movement with the S&P 500 and Nasdaq 100 slightly lower in premarket trading. Key movers included Fonar Corp surging 24.49% on a take-private deal announcement, TEN Holdings jumping 16.31% on a private placement, Boeing rising 0.58% following an $8.6 billion Pentagon contract, and Freeport-McMoRan gaining 1.36% as copper prices hit record highs. The Fed is expected to hold rates steady in January with 83.9% probability.Benzinga · Dec 30, 2025

Why Is Dermata Therapeutics Stock Surging Wednesday?Dermata Therapeutics (NASDAQ: DRMA) stock surged 20.10% on Wednesday following the announcement of a $12.4 million private placement offering. The company will issue 2,022,062 common shares and warrants priced at $2.04 per share, with expected gross proceeds of $4.1 million. If warrants are fully exercised, the company could raise an additional $8.3 million. Net proceeds will fund consumer research, OTC acne kit launch activities, and working capital. The stock is trading near its 52-week low of $1.96.Benzinga · Dec 24, 2025

Why Enphase Energy Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - BenzingaEnphase Energy reported mixed Q2 results, leading to a rise in its stock price. Several other companies saw significant pre-market movements, both positive and negative, due to various news and earnings reports.Benzinga · Jul 24, 2024

Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day SessionShares of Applied Therapeutics, Inc. (NASDAQ: APLT) shares fell sharply during Friday’s session after the company released topline results of the ARISE-HF Phase 3 trial of AT-001 (caficrestat) in patients with Diabetic Cardiomyopathy (DbCM) at high risk of progression to overt heart failure. The study's primary endpoint was stabilization or improvement in cardiac functional capacity as measured by Peak VO2 in patients treated with AT-001 1500mg twice daily (BID) compared to placebo. Applied Therapeutics shares dipped 35.6% to $2.4498 on Friday. Here are some other stocks moving in today's mid-day session. Gainers Ainos, Inc.(NASDAQ: AIMD) jumped 112.6% to $3.6805 after falling more than 12% on Thursday. Revelstone Capital Acquisition Corp. (NASDAQ: RCAC) shares climbed 89.6% to $10.71. Revelstone Capital Acquisition cancelled special meeting to approve business combination with Set Jet, Inc. Banzai International, Inc. (NASDAQ: BNZI) surged 74% to $2.92. Banzai International signed a non-binding letter of intent to acquire IGLeads, a cutting-edge automated lead generation platform. Safe and Green Development Corporation (NASDAQ: SGD) shares rose 56.5% to $2.1307. Safe And Green Development recently issued an update on LOI for acquisition of Xene AI Software platform. NexImmune, Inc. (NASDAQ: NEXI) gained 30% to $7.67 Dermata Therapeutics, Inc. (NASDAQ: DRMA) rose climbed 27.8% to $0.78 after the company announced the issuance of a new patent in Japan for its DMT410 program for the treatment of hyperhidrosis. Polished.com Inc. (NYSE: POL) gained 27.2% to $8.05. Swvl Holdings Corp. (NASDAQ: SWVL) gained 27.2% to $2.90. PolyPid Ltd. (NASDAQ: PYPD) gained 25% to $8.44. PolyPid announced $16.2 million private placement of 3,371,312 shares at $4.81 per share. AxoGen, Inc. (NASDAQ: AXGN) jumped 20.4% to $8.13 as the company reported ...Benzinga · Jan 5, 2024

Dow Turns Lower; ISM Services PMI Falls In DecemberU.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 70 points on Friday. The Dow traded down 0.19% to 37,369.52 while the NASDAQ rose 0.16% to 14,533.16. The S&P 500 also rose, gaining, 0.12% to 4,694.09. Check This Out: Cramer Says This 'Inexpensive' Stock Is 'Doing Some Great Things With Aerospace' Leading and Lagging Sectors Consumer discretionary shares jumped by 0.9% on Friday. In trading on Friday, health care shares rose by just 0.1%. Top Headline The ISM services PMI declined to 50.6 in December, recording the weakest reading in seven months, versus November’s reading of 52.7. Equities Trading UP Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares shot up 24% to $0.7593 after the company announced the issuance of a new patent in Japan for its DMT410 program for hyperhidrosis (excessive sweating that's not always related to heat or exercise). Shares of Banzai International, Inc. (NASDAQ: BNZI) got a boost, surging 94% to $3.2141. Banzai International signed a non-binding letter of intent to acquire IGLeads, a cutting-edge automated lead generation platform. Revelstone Capital Acquisition Corp. (NASDAQ: RCAC) shares were also up, gaining 90% to $10.74. Revelstone Capital Acquisition cancelled special meeting to approve business combination with Set Jet, Inc. Equities Trading DOWN Applied Therapeutics, Inc. (NASDAQ: APLT) shares dropped 35% to $2.4750 after the company released ...Benzinga · Jan 5, 2024

3 Essential Strategies for Penny Stocks Trading in 2024Are you using these penny stocks trading strategies? The post 3 Essential Strategies for Penny Stocks Trading in 2024 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.PennyStocks · Dec 18, 2023

Dermata (DRMA) Up on FDA Nod to Begin Pivotal Study of Acne DrugDermata (DRMA) announces reaching an agreement with the FDA to begin a late-stage pivotal clinical program for its acne treatment candidate, DMT310. The stock rises 7%.Zacks Investment Research · Nov 17, 2023

Why Children's Place Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionShares of The Children's Place, Inc. (NASDAQ: PLCE) moved lower during Thursday’s session following weak quarterly earnings. Children's Place posted adjusted earnings of $3.22 per share, missing market estimates of $3.56 per share. The company’s quarterly sales came in at $480.23 million versus estimates of $471.82 million, according to Benzinga Pro. Children's Place shares tumbled 25.6% to $21.23 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers WaveDancer, Inc. (NASDAQ: WAVD) climbed 80.1% to $2.7201 after the company inked a definitive merger agreement with Firefly Neuroscience in an all-stock transaction. Apollomics, Inc. (NASDAQ: APLM) shares climbed 51.7% to $1.3199 after the company reported the first approval of vebreltinib for MET exon 14 skip non-small cell lung cancer. Dermata Therapeutics, Inc. (NASDAQ: DRMA) gained 29.4% to $0.8426. Dermata Therapeutics announced agreement with the U.S. FDA on the DMT310 Phase 3 clinical protocols for the treatment of acne. Janover Inc. (NASDAQ: JNVR) gained 20.1% to $0.8478. Janover announced a $1 million share repurchase program. Advent Technologies Holdings, Inc. (NASDAQ: ADN) gained 16.4% to $0.5360 as the company received funding update for €60 million to launch Green HiPo IPCEI project. SenesTech, Inc. (NASDAQ:Benzinga · Nov 16, 2023

DRMADermata Therapeutics, Inc. Common Stock

DRMA

Pay with—

Start Trading

Available Balance0.00

Your PositionYou don't own any DRMA yet.

Related Tickers

Earnings

Mkt Cap

$4.0M

Volume

21.05K

Next Earnings

November 13th